Cullinan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fenton Mary Kay
Cullinan Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Fenton Mary Kay
Cullinan Therapeutics | 8-K: Current report
Cullinan Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deerfield Mgmt, L.P.(5.71%),Deerfield Management Company, L.P.(5.71%), etc.
Cullinan Oncology | 8-K: Current report
Cullinan Oncology | 3: Initial statement of beneficial ownership of securities-Officer Nguyen Nate
Cullinan Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cullinan Oncology | 10-K: Annual report
Cullinan Oncology | 8-K: Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Savill Corrine
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer AHMED NADIM
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Michaelson Jennifer
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer SUMER JACQUELYN L
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Trigilio Jeffrey
Cullinan Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Blue Owl Capital Holdings LP(7.99%)
Cullinan Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morana Jovan-Embiricos(5.09%),Globeways Holdings II Ltd.(2.37%), etc.
Cullinan Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
Cullinan Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.14%)
Cullinan Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Franklin Resources, Inc.(7.7%),Franklin Advisers, Inc.(7.6%)
Cullinan Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Savill Corrine
No Data